The Precision Peptide Company Inc
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Pratapvir Sandhu
- Full Time Employees
- 2
- Sector
- Consumer Cyclical
- Industry
- Restaurants
- Address
- 543 Granville Street Vancouver BC Canada V6C 1X8
- IPO Date
- Aug 25, 2022
- Website
- precisionpeptidecompany.com
- Similar Companies
- Business
- Pangea Natural Foods Inc. (PNGAF) manufactures and distributes plant-based food products and innovative wellness solutions focused on clean-label nutrition and non-injectable peptide therapies in North America. The company offers plant-based patties; old fashioned ghee made from grass-fed organic New Zealand butter; energy gel with apple-based honey for rapid nutrient delivery; vitality, sunshine, and greens blends; plant-based recovery drinks; munchie mix; and co-packing, manufacturing, supply-chain, and distribution services for third-party food and beverage companies; through its subsidiary Amino Innovations Corp., it provides peptide therapies including BPC for rapid muscle and joint recovery, and products targeting stress management, gut health, longevity, hair health, skin repair, sleep health, and immune support via oral and topical delivery systems. Products reach consumers through company websites, over 500 retail outlets across Canada and the United States such as Loblaws, Sobeys, Whole Foods, Save-On-Foods, Choices Markets, and select Air Canada and WestJet flights, as well as wholesale networks. Founded in 2021 and headquartered in Vancouver, British Columbia, Canada, with operations in Surrey, British Columbia, the company serves the packaged foods and consumer wellness sectors targeting health-conscious individuals and growing food brands. In Q2 2025, Pangea completed the acquisition of Amino Innovations Corp. to expand into peptide-based wellness products and needle-less delivery systems; it secured CAD 500,000 in development capital through a private placement in January 2025 and anticipates receiving CAD 2.9 million in additional funding; earlier in 2024, it launched co-packing services for scalability and cost savings while opting not to acquire Glory Juice Co. to prioritize core brand expansion.
Company News
The Precision Peptide Company Announces Grants of RSUs and Stock Options
The Precision Peptide Company to Showcase Its Needle-Free Recovery Patch and Supplement Range at FitExpo Anaheim
The Precision Peptide Company Inc. Announces Development of Needle-Free Tirzepatide Transdermal Patch
The Precision Peptide Company Completes Migration of Amino Innovations Online Store and Customer Base to Company Website
The Precision Peptide Company Targets Launch of the Peptide Pen, Expanding Its U.S.-Made Product Platform
The Precision Peptide Company Opens Nationwide Retail Sales Days After FDA Panel Backs Six of Seven Peptides Under Review
The Precision Peptide Company Advances First-to-Market Thymosin Alpha-1 Patch for Immune Support
The Precision Peptide Company Applauds FDA Advisory Committee Vote on Expanded Pathway for BPC-157 and KPV
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch
The Precision Peptide Company Inc. Announces Closing of LIFE Offering of Common Shares
The Precision Peptide Company Inc. Receives 20,000-Unit Production Run of BPC-157 Transdermal Patches
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch
The Precision Peptide Company Activates Nationwide Direct-to-Consumer Peptide Sales with Retail Telehealth Website Launch
The Precision Peptide Company Appoints Certified Peptide Therapist and Integrative Health Coach Diane Stafrace to Advisory Board
The Precision Peptide Company's Needle-Free Recovery Patch Featured in Men's Health Magazine
The Precision Peptide Company Achieves LegitScript Healthcare Merchant Certification
The Precision Peptide Company Announces Release of The Human Upgrade with Dave Asprey Episode Featuring Chief Scientific Officer Justin Kirkland
The Precision Peptide Company Inc. Announces up to $2 Million LIFE Offering of Common Shares
The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure Partnership
The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC